USD 17.6 billion
Report ID:
SQMIG35H2154 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
100
|Figures:
66
Cell-Based Assays Market size was valued at USD 19.14 Billion in 2023 and is poised to grow from USD 20.81 Billion in 2024 to USD 40.72 Billion by 2032, growing at a CAGR of 8.75% during the forecast period (2025-2032).
The global research landscape, including major clinical trials and drug discovery efforts, was profoundly disrupted by the COVID-19 pandemic. To address research backlogs, researchers worldwide swiftly adopted efficient and time-sensitive methodologies. Moreover, a multitude of cell-based assays were specifically developed for detecting COVID-19 infections, with several tests gaining FDA approval for global emergency use. An illustrative example is the T-Detect COVID-19 routine T-cell test (by Adaptive Biotechnologies), which obtained Emergency Use Authorization from the U.S. FDA in May 2021. This innovative Next-Generation Sequencing (NGS)-based test facilitates the identification of T-cells recognizing SARS-CoV-2 antigens, confirming recent infections.
Cell-based drug screening assays have played an integral role in drug discovery research, enabling the meticulous selection of promising drug candidates from vast compound libraries. The scope of these assays spans a diverse spectrum, influenced by multifaceted considerations in various drug development trajectories. Anticipated advancements in drug discovery hold promise for fostering an environment conducive to industry growth. A compelling instance is the groundbreaking development unveiled in September 2022 by Fraunhofer Institute researchers—Proxidrugs—a therapeutic prospect harnessing cell-based waste disposal systems to address conditions like infections, cancer, and Alzheimer's disease. This underscores the versatility of cell-based assays in driving scientific innovation and therapeutic evolution.
The market is currently poised for robust growth due to factors such as surging demand for drug discovery, an escalated requirement for biotechnology research, and the mounting incidence of infectious diseases, cancer, autoimmune disorders, and genetic anomalies. Cell-based assays play a pivotal role in the drug discovery process, not only for validating potential drug candidates but also for lead profiling, analyzing cellular signaling, and assessing toxicity. A prime example is The Annexin V-Cy3 apoptosis detection kit (by Cell Biologics), which leverages fluorescence to detect apoptosis—a testament to the diverse applications of these assays in comprehensive cellular analysis.
US Cell-Based Assays Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 17.6 billion
Largest Segment
Basic Research, Drug Discovery
Fastest Growth
Drug Discovery
Growth Rate
8.75% CAGR
To get more reports on the above market click here to Buy The Report
The global cell-based assays market is segmented on the basis of product & services, application, end - use, region. By product & services, the market is segmented into reagents, assay kits, cell growth assays, reporter gene assays, cell death assays, second messenger assays, microplates, probes & labels, instruments & software, cell lines, primary cell lines, stem cell lines, immortalized cell lines. By application, the market is segmented into basic research, drug discovery, other applications. By end – use, the market is segmented into pharmaceutical and biotechnology companies, academic & research institutes, contract research organizations. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Cell-Based Assays Market Analysis By Product
Remarkably, it was the consumables sector that commanded a prominent position, emerging as the driving force within this dynamic market landscape. This ascendancy can be traced back to a multifaceted interplay of influential dynamics that underscore the integral role of consumables.
The consumables segment's domination can be chiefly attributed to its indispensable role and recurrent utilization within the operational framework of pharmaceutical and biopharmaceutical entities. These organizations consistently draw upon consumables as fundamental requisites for their laboratory activities, particularly in the context of conducting diverse cell-based assays. The consumables' indispensability in the execution of these assays spans a spectrum of applications, encompassing drug screening, toxicity assessments, and intricate cellular analyses.
Cell-Based Assays Market Analysis By Application
Notably, it was the drug discovery application segment that held a commanding position, securing the largest share within the market landscape. This prominence is underpinned by a confluence of factors contributing to its robust growth trajectory.
The remarkable dominance of the drug discovery segment can be attributed to a dynamic interplay of key drivers. A notable driver is the escalating investments in research and development (R&D), which continue to inject vitality into the drug discovery domain. Additionally, the market is invigorated by ongoing technological innovations that bolster the efficiency and efficacy of supportive processes integral to drug discovery initiatives.
Furthermore, the introduction of novel pharmaceutical compounds fuels the demand for advanced cell-based assays, which play a pivotal role in assessing drug activity, toxicity, and efficacy. This vital contribution to enhancing the drug development pipeline positions the drug discovery segment as a pivotal growth engine.
To get detailed analysis on other segments, Request For Free Sample Report
North America stands as the dominant force globally, commanding a substantial market share, and this is attributed to its well-established healthcare sector and the widespread adoption of cell-based assays. The United States, in particular, showcases a robust healthcare landscape and a remarkable proclivity towards utilizing cell-based assays. Notably, the escalating prevalence of chronic diseases such as cancer, osteoarthritis, and diabetes within the United States fuels an augmented demand for cell-based assays, especially in the realm of pioneering drug discoveries. This phenomenon significantly contributes to the market's expansion, acting as a pivotal growth catalyst.
For instance, the recently published Cancer Facts & Figures 2022 data by the American Cancer Society provides a compelling illustration. This report underscores that the United States is projected to witness a staggering 1.9 million new cancer cases and an estimated 609,360 cancer-related deaths, reinforcing the pressing need for advanced tools like cell-based assays to facilitate groundbreaking research and therapeutic interventions.
Conversely, the Asia-Pacific region, while not surpassing North America, emerges as a noteworthy contender in the global cell-based assays market. This region exhibits a burgeoning interest in adopting these assays, fueled by escalating healthcare awareness, increasing research endeavors, and a mounting emphasis on personalized medicine. As Asia-Pacific forges ahead, the potential for growth and innovation within the realm of cell-based assays remains a captivating prospect, contributing to the evolving dynamics of the global healthcare landscape.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Cell-Based Assays Market Drivers
Rise in Chronic Diseases
Personalized Medicine Emphasis
Cell-Based Assays Market Restraints
Cost and Resource Intensiveness
Complexity and Variability
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global cell-based assays market is marked by intense innovation, strategic collaborations, and a focus on cutting-edge technology to meet the expanding demands of drug discovery, toxicology studies, and biomedical research. Industry leaders like Thermo Fisher Scientific, Merck KGaA, and PerkinElmer have established their dominance through a combination of advanced assay development, extensive product portfolios, and global reach.
Emerging players and biotechnology startups contribute to the landscape's dynamism, infusing novel methodologies and specialized assays. Collaborations between academia, pharmaceutical giants, and technology firms further enrich the competitive milieu, fostering cross-disciplinary expertise and accelerating assay advancements. The market is witnessing a shift toward personalized medicine and precision therapies, propelling the need for high-throughput, clinically relevant cell-based assays. Automation and data integration are key drivers, streamlining processes and enhancing assay reproducibility.
Cell-Based Assays Market Top Player’s Company Profiles
Cell-Based Assays Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global cell-based assays market analysis, the global cell-based assays market stands as a dynamic and rapidly evolving sector, driven by advancements in cellular research, drug discovery, and disease understanding. The widespread adoption of innovative technologies and the integration of automation have revolutionized the landscape, facilitating efficient and high-throughput experimentation. As pharmaceutical and biotechnology industries continue to seek targeted therapies and personalized medicine approaches, the demand for sophisticated cell-based assays remains robust. The market's growth is underpinned by the rising focus on precision medicine, drug safety assessment, and toxicology studies. Moreover, collaborative efforts between academia and industry are fostering the development of novel assays, enhancing the market's prospects.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 17.6 billion |
Market size value in 2031 | USD 37.44 billion |
Growth Rate | 8.75% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Cell-Based Assays Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell-Based Assays Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell-Based Assays Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell-Based Assays Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2154
sales@skyquestt.com
USA +1 351-333-4748